Dr. Akhilesh Pandey obtained his medical degree from Armed Forces Medical College, Pune and completed his residency in Pathology at the Brigham and Women’s Hospital, Harvard Medical School, Boston, U.S.A. He obtained his Ph.D. from the University of Michigan, Ann Arbor, U.S.A. in Molecular Biology. He was a Postdoctoral Fellow in the laboratory of Dr. Harvey Lodish at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, U.S.A., where he used computational and molecular biology tools to clone and characterize a novel cytokine receptor. Later, as a Visiting Scientist in the group of Prof. Matthias Mann at the University of Southern Denmark, he developed the SILAC method for quantitative proteomics. He served as a Professor for 16 years at the McKusick-Nathans Institute of Genetic Medicine and the Departments of Biological Chemistry, Oncology and Pathology at the Johns Hopkins University School of Medicine.

He is currently a Professor in the Department of Laboratory Medicine and Pathology and the Center for Individualized Medicine at Mayo Clinic in Rochester, Minnesota where he oversees a systems biology laboratory. In proteomics, he has pioneered methods for quantitative proteomics, analysis of post-translational modifications, protein-protein interactions and proteogenomics. His interests are in developing novel assays for clinical diagnostics and in using systems biology approaches to study a variety of human diseases ranging from cancer and infectious diseases to inherited genetic disorders.

Dr. Pandey is a Professor in the Department of Laboratory Medicine and Pathology and the Center for Individualized Medicine at Mayo Clinic in Rochester, Minnesota, USA where he oversee a systems biology laboratory. He is a recipient of numerous prestigious awards including the Discovery in Proteomic Sciences Award by the Human Proteome Organization (HUPO). A Margdarshi Fellow by the Wellcome Trust/DBT India Alliance under which he established a Center for Molecular Medicine at NIMHANS in Bangalore, India. He serves as an Editorial Board member of Molecular and Cellular Proteomics, Proteomics and Journal of Clinical Investigation and as an Associate Editor of Clinical Proteomics.

Research laboratories

Systems Biology and Translational Medicine lab, Mayo Clinic, Rochester, Minnesota, USA

Our lab has pioneered the methods for quantitative proteomics, analysis of post-translational modifications, protein-protein interactions and proteogenomics. Our interests are in the development of novel assays for clinical diagnostics and in using systems biology approaches to study a variety of human diseases ranging from cancer and infectious diseases to inherited genetic disorders.

Advanced Diagnostics Laboratory, Mayo Clinic, Rochester, Minnesota, USA

Our lab has pioneered the methods for quantitative proteomics, analysis of post-translational modifications, protein-protein interactions and proteogenomics. Our interests are in the development of novel assays for clinical diagnostics and in using systems biology approaches to study a variety of human diseases ranging from cancer and infectious diseases to inherited genetic disorders.

Center for Molecular Medicine, NIMHANS, Bangalore, India​

​The overarching goal of establishing the Center for Molecular Medicine is to establish a multi-disciplinary scientific team that will leverage the outstanding clinical, research and technological capabilities for research and translation of research findings into clinical medicine. Research program is centered on several broad themes: Signaling in cancer, cancer and personalized medicine, neurological disorders, protein biomarkers and omics approaches in microbiology.

Research Institute

Institute of Bioinformatics, Bangalore, India

The Institute of Bioinformatics is a not-for-profit organization engaged in research in Bioinformatics. This institute is located in Bangalore, India and was established in May 2002. The Institute of Bioinformatics emphasizes cutting edge research in Databases, Computational Genomics, Proteomics and Comparative Genomics. The initial goal of this Institute was to create a freely available Human Protein Reference Database using open source technologies and to experimentally verify predicted human genes using molecular biology and proteomics-based methods. 

 

Technologies